1. 1154PA phase I study of MEDI1873, a novel GITR agonist, in advanced solid tumors. (23rd October 2018) Authors: Denlinger, C S; Infante, J R; Aljumaily, R; Naing, A; Chintakuntlawar, A; Rizvi, N A; Ross, H; Gordon, M; Kumar, R; Ma, M; Yan, L; Vicini, P; Standifer, N; Cann, J; Perera, A; Durham, N; Krishnan, S; Balmanoukian, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 439PProspective validation of prognostic scores to improve patient selection for immuno-oncology trials. (23rd October 2018) Authors: Massard, C; Segal, N H; Cho, D C; Papadimitrakopoulou, V A; Rizvi, N A; Cho, B C; Yu, L; Yang, H; Hsieh, H-J; Zhang, J; Zhao, W; Gao, G; Guo, X; Abdullah, S; Englert, J; Soria, J-C; Dar, M; Roskos, L; Ferte, C; Antonia, S J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. LBA6Durvalumab with or without tremelimumab vs platinum-based chemotherapy as first-line treatment for metastatic non-small cell lung cancer: MYSTIC. (17th December 2018) Authors: Rizvi, N A; Chul Cho, B; Reinmuth, N; Lee, K H; Ahn, M-J; Luft, A; van den Heuvel, M; Cobo, M; Smolin, A; Vicente, D; Moiseyenko, V; Antonia, S J; Le Moulec, S; Robinet, G; Natale, R; Nakagawa, K; Zhao, L; Stockman, P K; Chand, V; Peters, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 10 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗